{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T15:44:19Z","timestamp":1793634259485,"version":"4.5.1"},"reference-count":107,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C18281\/A29019"],"award-info":[{"award-number":["C18281\/A29019"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015846","name":"Llywodraeth Cymru","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015846","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010388","name":"Saint David&apos;s Medical Foundation","doi-asserted-by":"publisher","award":["1122688"],"award-info":[{"award-number":["1122688"]}],"id":[{"id":"10.13039\/100010388","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X000095\/1"],"award-info":[{"award-number":["MR\/X000095\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.molmet.2024.101900","type":"journal-article","created":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T04:07:04Z","timestamp":1707797224000},"page":"101900","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer"],"prefix":"10.1016","volume":"81","author":[{"given":"M. Rufaik","family":"Farook","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zack","family":"Croxford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffan","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D.","family":"Horlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy K.","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Stanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Mark","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A.","family":"Thornton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. Martin","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma E.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Cronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.20892\/j.issn.2095-3941.2016.0084","article-title":"Epidemiology of ovarian cancer: a review","volume":"14","author":"Reid","year":"2017","journal-title":"Cancer Biology & Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040952","article-title":"High-grade serous ovarian cancer: basic sciences, clinical and therapeutic standpoints","volume":"20","author":"Lisio","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Langyel","year":"2010","journal-title":"Am J Pathol"},{"issue":"11","key":"10.1016\/j.molmet.2024.101900_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2492","article-title":"Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth","volume":"17","author":"Nieman","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.molmet.2024.101900_bib5","first-page":"22","article-title":"Ovarian cancer","volume":"2","author":"Matulonis","year":"2016","journal-title":"Nat Rev Dis Prim"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s12276-020-0375-3","article-title":"Amino acids in cancer","volume":"52","author":"Lieu","year":"2020","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.molmet.2024.101900_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.00281","article-title":"Metabolic plasticity in chemotherapy resistance","volume":"10","author":"Desbats","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.molmet.2024.101900_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.semcancer.2018.10.002","article-title":"Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells","volume":"53","author":"Ahmed","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/msb.20134892","article-title":"Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer","volume":"10","author":"Yang","year":"2014","journal-title":"Mol Syst Biol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/msb.20134892","article-title":"Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer","volume":"10","author":"Yang","year":"2014","journal-title":"Mol Syst Biol"},{"key":"10.1016\/j.molmet.2024.101900_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cca.2021.03.012","article-title":"Serum metabolite signatures of epithelial ovarian cancer based on targeted metabolomics","volume":"518","author":"Wang","year":"2021","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"49","key":"10.1016\/j.molmet.2024.101900_bib13","doi-asserted-by":"crossref","first-page":"19345","DOI":"10.1073\/pnas.0709747104","article-title":"Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis","volume":"104","author":"DeBerardinis","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6090","key":"10.1016\/j.molmet.2024.101900_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337","author":"Herzig","year":"2012","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib15","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A\u00a0role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.cmet.2019.11.002","article-title":"Regulation of tumor initiation by the mitochondrial pyruvate carrier","volume":"31","author":"Bensard","year":"2020","journal-title":"Cell Metabol"},{"issue":"12","key":"10.1016\/j.molmet.2024.101900_bib17","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/sj.onc.1201654","article-title":"Physical map of the D6S149-D6S193 region on chromosome 6q27 and its involvement in benign surface epithelial ovarian tumours","volume":"16","author":"Tibiletti","year":"1998","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib18","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2024.101900_bib19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/msb.20134892","article-title":"Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer","volume":"10","author":"Yang","year":"2014","journal-title":"Mol Syst Biol"},{"issue":"7","key":"10.1016\/j.molmet.2024.101900_bib20","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/jcb.26814","article-title":"Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy","volume":"119","author":"Masamha","year":"2018","journal-title":"J\u00a0Cell Biochem"},{"issue":"8","key":"10.1016\/j.molmet.2024.101900_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib22","first-page":"71","article-title":"Proline metabolism and cancer: emerging links to glutamine and collagen","volume":"18","author":"Phang","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"7591","key":"10.1016\/j.molmet.2024.101900_bib23","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16982","article-title":"Tumour-specific proline vulnerability uncovered by differential ribosome codon reading","volume":"530","author":"Loayza-Puch","year":"2016","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib24","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bjc.2017.387","article-title":"MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer","volume":"118","author":"Craze","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/j.molmet.2024.101900_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15267","article-title":"Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells","volume":"8","author":"Elia","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/ars.2017.7350","article-title":"Proline metabolism in cell regulation and cancer biology: recent advances and hypotheses","volume":"30","author":"Phang","year":"2019","journal-title":"Antioxidants Redox Signal"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabol"},{"key":"10.1016\/j.molmet.2024.101900_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s40170-015-0128-2","article-title":"Mitochondria as biosynthetic factories for cancer proliferation","volume":"3","author":"Ahn","year":"2015","journal-title":"Cancer Metabol"},{"issue":"17","key":"10.1016\/j.molmet.2024.101900_bib29","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1080\/15384101.2016.1191256","article-title":"Monitoring amino acid deficiencies in cancer","volume":"15","author":"Loayza-Puch","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.molmet.2024.101900_bib30","article-title":"Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"issue":"36","key":"10.1016\/j.molmet.2024.101900_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh2023","article-title":"Loss of attachment promotes proline accumulation and excretion in cancer cells","volume":"9","author":"Pilley","year":"2023","journal-title":"Sci Adv"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib32","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/1097-0142(19950215)75:4<1010::AID-CNCR2820750417>3.0.CO;2-O","article-title":"Immunohistochemical study of type I collagen and type I pN-collagen in benign and malignant ovarian neoplasms","volume":"75","author":"Zhu","year":"1995","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.molmet.2024.101900_bib33","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1158\/1078-0432.CCR-05-2141","article-title":"Intraperitoneal immunotherapy for metastatic ovarian carcinoma: resistance of intratumoral collagen to antibody penetration","volume":"12","author":"Choi","year":"2006","journal-title":"Clin Cancer Res"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S1535-6108(03)00058-8","article-title":"Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells","volume":"3","author":"Sherman-Baust","year":"2003","journal-title":"Cancer Cell"},{"issue":"7750","key":"10.1016\/j.molmet.2024.101900_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41586-019-0977-x","article-title":"Breast cancer cells rely on environmental pyruvate to shape the metastatic niche","volume":"568","author":"Elia","year":"2019","journal-title":"Nature"},{"issue":"7353","key":"10.1016\/j.molmet.2024.101900_bib36","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Bell","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.molmet.2024.101900_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib38","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(T)(-Delta Delta C) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.molcel.2015.08.013","article-title":"Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth","volume":"60","author":"Vincent","year":"2015","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib40","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","article-title":"AMPK is a negative regulator of the warburg effect and suppresses tumor growth in\u00a0vivo","volume":"17","author":"Faubert","year":"2013","journal-title":"Cell Metabol"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib41","doi-asserted-by":"crossref","DOI":"10.1186\/2049-3002-1-22","article-title":"PGC-1alpha supports glutamine metabolism in breast cancer","volume":"1","author":"McGuirk","year":"2013","journal-title":"Cancer Metabol"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib42","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in\u00a0vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib43","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib44","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.molmet.2024.101900_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12645","article-title":"Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status","volume":"7","author":"Coscia","year":"2016","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molcel.2014.09.024","article-title":"Regulation of substrate utilization by the mitochondrial pyruvate carrier","volume":"56","author":"Vacanti","year":"2014","journal-title":"Mol Cell"},{"issue":"6090","key":"10.1016\/j.molmet.2024.101900_bib47","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1126\/science.1218099","article-title":"A\u00a0mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans","volume":"337","author":"Bricker","year":"2012","journal-title":"Science"},{"issue":"2\u20133","key":"10.1016\/j.molmet.2024.101900_bib48","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bbabio.2004.12.005","article-title":"Identification and characterisation of a new class of highly specific and potent inhibitors of the mitochondrial pyruvate carrier","volume":"1707","author":"Hildyard","year":"2005","journal-title":"Biochim Biophys Acta Bioenerg"},{"issue":"9","key":"10.1016\/j.molmet.2024.101900_bib49","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1073\/pnas.1812941116","article-title":"Loss of MPC1 reprograms retinal metabolism to impair visual function","volume":"116","author":"Grenell","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"10.1016\/j.molmet.2024.101900_bib50","doi-asserted-by":"crossref","first-page":"36129","DOI":"10.1074\/jbc.M113.507285","article-title":"Inhibition of mitochondrial pyruvate transport by zaprinast causes massive accumulation of aspartate at the expense of glutamate in the retina","volume":"288","author":"Du","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib51","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/s41467-018-03525-0","article-title":"Interruption of lactate uptake by inhibiting mitochondrial pyruvate transport unravels\u00a0direct\u00a0antitumor and radiosensitizing effects","volume":"9","author":"Corbet","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1083\/jcb.201612067","article-title":"Inhibition of the mitochondrial pyruvate carrier protects from excitotoxic neuronal death","volume":"216","author":"Divakaruni","year":"2017","journal-title":"J\u00a0Cell Biol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib53","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molcel.2014.09.025","article-title":"Glutamine oxidation maintains the TCA cycle and cell survival during impaired mitochondrial pyruvate transport","volume":"56","author":"Yang","year":"2014","journal-title":"Mol Cell"},{"key":"10.1016\/j.molmet.2024.101900_bib54","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation","volume":"343 Pt 2","author":"Halestrap","year":"1999","journal-title":"Biochem J"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib55","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/s42255-023-00800-3","article-title":"Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages","volume":"5","author":"Ran","year":"2023","journal-title":"Nat Metab"},{"issue":"9","key":"10.1016\/j.molmet.2024.101900_bib56","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","article-title":"Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis","volume":"43","author":"Locasale","year":"2011","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.molmet.2024.101900_bib57","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/ng.3421","article-title":"NRF2 regulates serine biosynthesis in non-small cell lung cancer","volume":"47","author":"DeNicola","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/j.molmet.2024.101900_bib58","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.canlet.2020.01.036","article-title":"The PHGDH enigma: do cancer cells only need serine or also a redox modulator?","volume":"476","author":"Li","year":"2020","journal-title":"Cancer Lett"},{"key":"10.1016\/j.molmet.2024.101900_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102065","article-title":"Lactate and glutamine support NADPH generation in cancer cells under glucose deprived conditions","volume":"46","author":"Ying","year":"2021","journal-title":"Redox Biol"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib60","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0262364","article-title":"Increased mitochondrial proline metabolism sustains proliferation and survival of colorectal cancer cells","volume":"17","author":"Alaqbi","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.molmet.2024.101900_bib61","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1146\/annurev.bi.49.070180.005041","article-title":"Metabolism of proline and the hydroxyprolines","volume":"49","author":"Adams","year":"1980","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.molmet.2024.101900_bib62","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41420-020-00341-8","article-title":"The Janus-like role of proline metabolism in cancer","volume":"6","author":"Burke","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib63","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/ijc.22666","article-title":"Aberrant regulation of argininosuccinate synthetase by TNF-alpha in human epithelial ovarian cancer","volume":"121","author":"Szlosarek","year":"2007","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/cjp2.4","article-title":"Differential expression of argininosuccinate synthetase in serous and non-serous ovarian carcinomas","volume":"1","author":"Cheon","year":"2015","journal-title":"J\u00a0Pathol Clin Res"},{"issue":"29","key":"10.1016\/j.molmet.2024.101900_bib65","doi-asserted-by":"crossref","first-page":"10450","DOI":"10.1073\/pnas.1409778111","article-title":"Alteration of the lipid profile in lymphomas induced by MYC overexpression","volume":"111","author":"Eberlin","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"10.1016\/j.molmet.2024.101900_bib66","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1073\/pnas.1203244109","article-title":"Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC","volume":"109","author":"Liu","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.molmet.2024.101900_bib67","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.redox.2014.07.003","article-title":"Sources of superoxide\/H2O2 during mitochondrial proline oxidation","volume":"2","author":"Goncalves","year":"2014","journal-title":"Redox Biol"},{"issue":"12","key":"10.1016\/j.molmet.2024.101900_bib68","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00726-021-03051-2","article-title":"Proline metabolism and redox; maintaining a balance in health and disease","volume":"53","author":"Vettore","year":"2021","journal-title":"Amino Acids"},{"issue":"8","key":"10.1016\/j.molmet.2024.101900_bib69","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019103334","article-title":"Proline biosynthesis is a vent for TGF beta-induced mitochondrial redox stress","volume":"39","author":"Schworer","year":"2020","journal-title":"EMBO J"},{"key":"10.1016\/j.molmet.2024.101900_bib70","doi-asserted-by":"crossref","DOI":"10.1038\/srep18846","article-title":"PYCR1 and PYCR2 interact and collaborate with RRM2B to protect cells from overt oxidative stress","volume":"6","author":"Kuo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.molmet.2024.101900_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.abb.2015.11.023","article-title":"Glutathionists in the battlefield of gamma-glutamyl cycle","volume":"595","author":"Inoue","year":"2016","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib72","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13054-019-2450-5","article-title":"Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock","volume":"23","author":"Gamarra","year":"2019","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib73","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1158\/1078-0432.CCR-13-1256","article-title":"A\u00a0collagen-remodeling gene signature regulated by TGF-beta signaling is associated with metastasis and poor survival in serous ovarian cancer","volume":"20","author":"Cheon","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.molmet.2024.101900_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576565","article-title":"Detailed molecular mechanism and potential drugs for COL1A1 in carboplatin-resistant ovarian cancer","volume":"10","author":"Yang","year":"2021","journal-title":"Front Oncol"},{"issue":"11","key":"10.1016\/j.molmet.2024.101900_bib75","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.1111\/jcmm.15271","article-title":"Systematic prediction of key genes for ovarian cancer by co-expression network analysis","volume":"24","author":"Wang","year":"2020","journal-title":"J\u00a0Cell Mol Med"},{"issue":"23","key":"10.1016\/j.molmet.2024.101900_bib76","first-page":"6744","article-title":"Differential gene expression between normal and tumor-derived ovarian epithelial cells","volume":"60","author":"Ismail","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.molmet.2024.101900_bib77","doi-asserted-by":"crossref","DOI":"10.1038\/srep30061","article-title":"Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells","volume":"6","author":"Ahmed","year":"2016","journal-title":"Sci Rep"},{"issue":"3\u20134","key":"10.1016\/j.molmet.2024.101900_bib78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.cytogfr.2008.04.004","article-title":"Targeting tumors with LIGHT to generate metastasis-clearing immunity","volume":"19","author":"Yu","year":"2008","journal-title":"Cytokine Growth Factor Rev"},{"issue":"11","key":"10.1016\/j.molmet.2024.101900_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047201","article-title":"Paradoxical impact of two folate receptors, FRalpha and RFC, in ovarian cancer: effect on cell proliferation, invasion and clinical outcome","volume":"7","author":"Siu","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib80","first-page":"15","article-title":"FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells","volume":"11","author":"Huang","year":"2018","journal-title":"J\u00a0Ovarian Res"},{"issue":"4","key":"10.1016\/j.molmet.2024.101900_bib81","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the intersections between metabolism and cancer biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"6090","key":"10.1016\/j.molmet.2024.101900_bib82","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1218530","article-title":"Identification and functional expression of the mitochondrial pyruvate carrier","volume":"337","author":"Herzig","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib83","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1186\/s12885-016-2941-6","article-title":"MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib84","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s42255-018-0002-y","article-title":"Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer","volume":"1","author":"Bader","year":"2019","journal-title":"Nat Metab"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib85","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/s41419-019-1324-8","article-title":"MPC1 deficiency accelerates lung adenocarcinoma progression through the STAT3 pathway","volume":"10","author":"Zou","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.molmet.2024.101900_bib86","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2021.03.013","article-title":"Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition","volume":"507","author":"You","year":"2021","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib87","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1038\/s41598-018-21740-z","article-title":"Human mitochondrial pyruvate carrier 2 as an autonomous membrane transporter","volume":"8","author":"Nagampalli","year":"2018","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib88","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2015.06.035","article-title":"Monitoring mitochondrial pyruvate carrier activity in real time using a BRET-based biosensor: investigation of the warburg effect","volume":"59","author":"Compan","year":"2015","journal-title":"Mol Cell"},{"issue":"7","key":"10.1016\/j.molmet.2024.101900_bib89","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41556-018-0125-0","article-title":"Aspartate is an endogenous metabolic limitation for tumour growth","volume":"20","author":"Sullivan","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"10","key":"10.1016\/j.molmet.2024.101900_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41556-018-0184-2","article-title":"Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours (vol 20, pg 775, 2018)","volume":"20","author":"Garcia-Bermudez","year":"2018","journal-title":"Nat Cell Biol"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib91","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2015.07.016","article-title":"An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis","volume":"162","author":"Birsoy","year":"2015","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2024.101900_bib92","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.molcel.2014.09.026","article-title":"A\u00a0role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth","volume":"56","author":"Schell","year":"2014","journal-title":"Mol Cell"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib93","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110320","article-title":"Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions","volume":"38","author":"Westbrook","year":"2022","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.molmet.2024.101900_bib94","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.celrep.2018.02.084","article-title":"Oncogenic IDH1 mutations promote enhanced proline synthesis through PYCR1 to support the maintenance of mitochondrial redox homeostasis","volume":"22","author":"Hollinshead","year":"2018","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.molmet.2024.101900_bib95","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/bjc.2014.567","article-title":"Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study","volume":"111","author":"Kabel","year":"2014","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib96","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1158\/1078-0432.CCR-17-1707","article-title":"Global metabolic profiling identifies a pivotal role of proline and hydroxyproline metabolism in supporting hypoxic response in hepatocellular carcinoma","volume":"24","author":"Tang","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib97","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib98","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","article-title":"Integrated proteogenomic characterization of HBV-related hepatocellular carcinoma","volume":"179","author":"Gao","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.molmet.2024.101900_bib99","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajhg.2015.03.003","article-title":"Mutations in PYCR2, encoding pyrroline-5-carboxylate reductase 2, cause microcephaly and hypomyelination","volume":"96","author":"Nakayama","year":"2015","journal-title":"Am J Hum Genet"},{"issue":"16","key":"10.1016\/j.molmet.2024.101900_bib100","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"7353","key":"10.1016\/j.molmet.2024.101900_bib101","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research","year":"2011","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.molmet.2024.101900_bib102","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/9511","article-title":"Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in\u00a0vivo","volume":"5","author":"Sethi","year":"1999","journal-title":"Nat Med"},{"issue":"24","key":"10.1016\/j.molmet.2024.101900_bib103","doi-asserted-by":"crossref","first-page":"16607","DOI":"10.1074\/jbc.M510192200","article-title":"The C5 domain of the collagen VI alpha3(VI) chain is critical for extracellular microfibril formation and is present in the extracellular matrix of cultured cells","volume":"281","author":"Lamande","year":"2006","journal-title":"J\u00a0Biol Chem"},{"issue":"2","key":"10.1016\/j.molmet.2024.101900_bib104","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1006\/bbrc.2001.6227","article-title":"The C5 domain of Col6A3 is cleaved off from the Col6 fibrils immediately after secretion","volume":"290","author":"Aigner","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"10.1016\/j.molmet.2024.101900_bib105","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1172\/JCI63930","article-title":"Adipocyte-derived endotrophin promotes malignant tumor progression","volume":"122","author":"Park","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib106","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.bjc.6605107","article-title":"Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer","volume":"101","author":"Ohlund","year":"2009","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.molmet.2024.101900_bib107","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjc.6604443","article-title":"Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers","volume":"99","author":"Mazouni","year":"2008","journal-title":"Br J Cancer"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877824000310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:34:30Z","timestamp":1761957270000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877824000310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":107,"alternative-id":["S2212877824000310"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101900","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loss of mitochondrial pyruvate carrier 1 supports proline-dependent proliferation and collagen biosynthesis in ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2024.101900","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101900"}}